ASIA News
The latest upgrade makes it easier for people to control who sees and accesses their health information.
On March 9, the Innovation and Technology Commission (ITC) in Hong Kong launched a special call under the Public Sector Trial Scheme for projects to support product development and application of technologies for the prevention and control of COVID-19.
iThermo reduces the need for manual temperature screening, and provides prompts where secondary checks can be carried out for feverish persons identified by the solution.
A new study, conducted by Korean academic hospitals and Lunit, a medical AI company specializing in developing AI solutions for radiology and oncology, demonstrated the benefits of AI-aided breast cancer detection from mammography images.
Japanese giant Sumitomo Dainippon Pharma and Oxford-headquartered AI-driven drug discovery company Exscientia yesterday announced that they have created a new compound which is in the process of entering human clinical trials in Japan.
These services include digital diagnostic pathology, access to proton therapy information, teaching surgery, an AI-enabled care for in-patients and an autonomous robot for operating rooms.
Better health information systems that allow every Thai to access their personal health information, including diabetes risk and screening records, could contribute to reducing unmet need.
“This is a big step forward in personalizing cancer treatment and ensuring better patient outcomes,” said Professor Lim Chwee Teck, Mechanobiology Institute, NUS Biomedical Engineering.
SPONSORED
|
10:53 pm |
January 13, 2020
|
10:53 pm |
January 13, 2020
“Our goal is to make all of a patient’s health record available in our clinical portal so that when a clinician brings up a patient’s record, they can have all the information they need,” said S. Wissmann, director of information management, Mater.
The new SERI-NTU Advanced Ocular Engineering (STANCE) Laboratory is a collaboration between NTU, SNEC and SERI.